{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:35:30Z","timestamp":1791995730443,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012905","name":"Department of Science and Technology of Shandong Province","doi-asserted-by":"publisher","award":["202201041061"],"award-info":[{"award-number":["202201041061"]}],"id":[{"id":"10.13039\/100012905","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["ZR2023MH029"],"award-info":[{"award-number":["ZR2023MH029"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156112","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:06:58Z","timestamp":1752588418000},"page":"156112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Clinicopathological and molecular characteristics of papillary thyroid carcinoma with BRAF V600E and TERT promoter co-mutations"],"prefix":"10.1016","volume":"272","author":[{"given":"Ruijing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156112_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2025.156112_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2025.156112_bib3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid cancer incidence and mortality trends in the united states: 2000-2018","volume":"32","author":"Megwalu","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2025.156112_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","article-title":"Evolving understanding of the epidemiology of thyroid cancer","volume":"48","author":"Seib","year":"2019","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.prp.2025.156112_bib5","article-title":"LncRNAs associated with lymph node metastasis in thyroid cancer based on TCGA database","volume":"256","author":"Liu","year":"2024","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156112_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.prp.2025.156112_bib7","article-title":"Molecular testing in thyroid cancer diagnosis and management","volume":"37","author":"Sipos","year":"2023","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156112_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCO.0000000000000797","article-title":"BRAF mutations in thyroid cancer","volume":"34","author":"Scheffel","year":"2022","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.prp.2025.156112_bib9","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.31557\/APJCP.2022.23.12.4029","article-title":"BRAF V600E and novel somatic mutations in thyroid cancer of libyan patients","volume":"23","author":"Tounsi Guettiti","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2025.156112_bib10","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41467-022-29000-5","article-title":"Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2025.156112_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/ERC-07-0212","article-title":"BRAF(V600E) mutation and the biology of papillary thyroid cancer","volume":"15","author":"Frasca","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2025.156112_bib12","article-title":"Usefulness of CD56, BRAF and CD15 in the differential diagnosis of thyroid lesions with nuclear features of papillary carcinoma","volume":"271","author":"Onieva Carbajo","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156112_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12022-011-9184-5","article-title":"BRAF V600E mutation in papillary thyroid carcinoma: significant association with node metastases and extra thyroidal invasion","volume":"23","author":"Chakraborty","year":"2012","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.prp.2025.156112_bib14","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1002\/cam4.2467","article-title":"Spectrum of TERT promoter mutations and mechanisms of activation in thyroid cancer","volume":"8","author":"Panebianco","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2025.156112_bib15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1507\/endocrj.EJ23-0136","article-title":"TERT promoter mutations in thyroid cancer","volume":"70","author":"Matsuse","year":"2023","journal-title":"Endocr. J."},{"key":"10.1016\/j.prp.2025.156112_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-16-0219","article-title":"TERT promoter mutations and long-term survival in patients with thyroid cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2025.156112_bib17","first-page":"7","article-title":"[Interpretation of the 5th edition WHO classification of follicular cell derived thyroid tumors]","volume":"52","author":"Liu","year":"2023","journal-title":"Zhonghua Bing. Li Xue Za Zhi"},{"key":"10.1016\/j.prp.2025.156112_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/cen.13413","article-title":"Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis","volume":"87","author":"Vuong","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.prp.2025.156112_bib19","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/ERC-15-0533","article-title":"TERT promoter mutations in thyroid cancer","volume":"23","author":"Liu","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2025.156112_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011548","article-title":"The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer","volume":"97","author":"Jin","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2025.156112_bib21","article-title":"Associations of clinicopathologic features and mutation status with lateral lymph node metastasis as a predictor of disease-free survival in papillary thyroid carcinoma","volume":"269","author":"Nguyen","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.prp.2025.156112_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/ERC-15-0057","article-title":"Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT","volume":"22","author":"Dettmer","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.prp.2025.156112_bib23","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1210\/en.2019-00315","article-title":"Impact of BRAF V600E and TERT promoter mutations on response to therapy in papillary thyroid cancer","volume":"160","author":"Trybek","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.prp.2025.156112_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032023","article-title":"Modulation of unfolded protein response restores survival and function of beta-cells exposed to the endocrine disruptor bisphenol A","volume":"24","author":"Daian","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156112_bib25","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1210\/jc.2016-2785","article-title":"TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease","volume":"102","author":"Melo","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prp.2025.156112_bib26","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1007\/s00259-022-05820-x","article-title":"The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer","volume":"49","author":"Cao","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.prp.2025.156112_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2967\/jnumed.119.227652","article-title":"The genetic duet of BRAF V600E and TERT promoter mutations robustly predicts loss of radioiodine avidity in recurrent papillary thyroid cancer","volume":"61","author":"Liu","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.prp.2025.156112_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.eprac.2021.12.005","article-title":"Effect of BRAF(V600E) and TERT promoter mutations on thyroglobulin response in patients with distant-metastatic differentiated thyroid cancer","volume":"28","author":"Mu","year":"2022","journal-title":"Endocr. Pr."},{"key":"10.1016\/j.prp.2025.156112_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1530\/EC-17-0302","article-title":"NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features","volume":"7","author":"Tavares","year":"2018","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.prp.2025.156112_bib30","article-title":"GPX3 expression was down-regulated but positively correlated with poor outcome in human cancers","volume":"13","author":"Hu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2025.156112_bib31","doi-asserted-by":"crossref","first-page":"10848","DOI":"10.1038\/s41598-023-37932-1","article-title":"TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma","volume":"13","author":"Li","year":"2023","journal-title":"Sci. Rep."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:30:49Z","timestamp":1778747449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382500305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S034403382500305X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156112","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological and molecular characteristics of papillary thyroid carcinoma with BRAF V600E and TERT promoter co-mutations","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156112","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156112"}}